Drawing for DCPC

USPTO serial 78257385

DCPC

Reviewed by CopyMark Law Group

Reg. 2834657Status 710
Filing date
Status date
Registration date
Apr 20, 2004
Examiner
FAINT, MARY CATHERINE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with DCPC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

James M. Slattery

JAMES M SLATTERY BIRCH, STEWART, KOLASCH & BIRCH, LLPPO BOX 747FALLS CHURCH, VA 22040-0747UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Antibiotic pharmaceutical preparations; synthetic antiseptic pharmaceutical preparations; anti-infective pharmaceutical preparations; antiseptic pharmaceutical preparations; antiviral pharmaceutical preparations; analgesics; anti-inflammatory pharmaceutical preparations; sedatives; hypnotics; pharmaceutical preparations used in easing anxiousness; anti-psychotics; anti-depressants; cardiotonics; pharmaceutical preparations for use in the treatment of arrhythmia, hypertension, arterial angina pectoris, cardiovascular diseases, dyslipinemia diseases, respiratory system problems, digestive system problems, urinary diseases; medical preparations for slimming purposes; pharmaceutical preparations affecting blood and blood production systems; contraceptive preparations; anti-tumor preparations; vitamin preparations; biological preparations; biochemical medicines; antidotes; Traditional Chinese medicines, for clearing away heat, inducing diuresis and excreting dampness, warming the interior body, eliminating wind-dampness, regulating vital energy, improving appetite and digestion, arresting bleeding, promoting blood circulation and removing blood stasis, eliminating sputum and relieving cough and asthma, tranquilizing mind, calming liver and checking endogenous wind, inducing resuscitation, nourishing health, arresting secretion, and for the treatment of exterior syndrome; purgative traditional Chinese medicines; anthelmintics; aromatic traditional Chinese medicines for resolving dampness; Dietetic substances for medical use; royal jelly for medical useSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 26, 2010C8..CANCELLED SEC. 8 (6-YR)—
Apr 20, 2004R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 27, 2004PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 7, 2004NPUBNOTICE OF PUBLICATION—
Nov 12, 2003CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 12, 2003DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance